MARKET

ABEO

ABEO

Abeona
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.260
+0.020
+0.62%
After Hours: 3.259 -0.002 -0.05% 16:37 09/20 EDT
OPEN
3.230
PREV CLOSE
3.240
HIGH
3.395
LOW
3.190
VOLUME
806.45K
TURNOVER
--
52 WEEK HIGH
14.00
52 WEEK LOW
1.460
MARKET CAP
160.77M
P/E (TTM)
-2.0563
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ABEO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ABEO News

  • 32 Stocks Moving In Thursday's Mid-Day Session
  • Benzinga.3d ago
  • 52 Biggest Movers From Yesterday
  • Benzinga.3d ago
  • The Week Ahead In Biotech: Conference Presentations, IPO News Flow Take The Spotlight
  • Benzinga.09/08 15:01
  • Zafgen To Explore Strategic Options, With No Near-Term Resolution For Diabetes Drug
  • Benzinga.09/05 15:24

More

Industry

Biotechnology & Medical Research
+0.62%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About ABEO

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB). It is also developing ABO-101 (AAV-NAGLU) for Sanfilippo syndrome type B (MPS IIIB), ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL), ABO-202 (AAV-CLN1) for treatment of infantile Batten disease (INCL), EB-201 for epidermolysis bullosa, ABO-301 (AAV-FANCC) for Fanconi anemia disorder and ABO-302 using a novel CRISPR/Cas9-based gene editing approach to gene therapy for rare blood diseases. The Company also has a plasma-based protein therapy pipeline, including alpha-1 protease inhibitor (SDF Alpha) for inherited COPD, using its proprietary Salt Diafiltration ethanol-free process.
More

Webull offers Abeona Therapeutics Inc (ABEO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.